Press Releases

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member Former Vice Dean at East Carolina University’s Brody School of Medicine brings scientific and strategic expertise to lead the federally funded clinical research enterprise of this international CRO. Research Triangle Park, NC – April 19, 2022 – Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, has appointed Peter Schmidt, Ph.D., as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division. For over 30 years, Rho has worked closely with NIH/NIAID and other federal departments on groundbreaking clinical trial and epidemiologic studies, including the LEAP peanut allergy study. “I am thrilled to welcome Dr. Schmidt to Rho," said Dr. Laura Helms Reece, CEO, Rho. “He is a preeminent neuroscientist and recognized leader across federal, commercial and academic arenas. His expertise in clinical research is remarkable, and his command of central nervous system, infectious disease, and other indications is a great fit with Rho’s focus in those areas. I am eager to work with Dr. Schmidt as he brings exciting strategic and scientific leadership to our federal business. His experience and judgment will be great additions to our Executive Committee.”

Bora Pharmaceuticals to expand operations with $10m+ investment

Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library

Creative Peptides constructed a versatile total peptide library with its proprietary peptide design platform to accelerate peptide drug research.

BOC Sciences Unveils Comprehensive Custom Synthesis Services

BOC Sciences unveils its comprehensive custom synthesis services for worldwide partners engaged in biopharmaceutical, chemical, and life science research.

List Bio Raises $48.4 Million Series A for Global Scale-Up

List Bio will use an $48.4 million Series A investment to build a large-scale manufacturing facility in Fishers, Indiana, USA

Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

Panthera Biopartners has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment round will be used to fund further expansion in the UK and Western Europe.

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions Global CRO to demonstrate how data visualization can improve the conduct of clinical trials in a free webinar WHAT: Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, will discuss how ongoing access to real-time clinical study data and metrics is essential for efficient start-up and conduct of clinical trials in an upcoming webinar, “Using Advanced Data Visualization to Power Up Clinical Trials.” The webinar will take place on Wednesday, April 27, from 2-3 p.m. EST.

Creative Enzymes to Exhibit at the PEGS Boston Summit on May 2-6, 2022

Tower Cold Chain wins Queen’s Award for International Trade

For more information on Tower Cold Chain, visit https://bit.ly/3MicrTr

NorthX Biologics signs GMP manufacturing collaboration agreement with Abera Bioscience

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.

Curebase selected to launch a clinical investigation of a digital therapeutic for IPF

Curebase selected to launch a clinical investigation of a digital therapeutic for IPF

CD Formulation Launches Tailored Solutions for Increased Bioavailability Excipients

Alfa Chemistry Launches a Chemistry-Focused Technology Platform: Advanced and Flexible

CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities

CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities Company wins prestigious accolade for contribution to Pfizer/BioNTech BNT162b2 COVID-19 vaccine development King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has won the Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities.

BioIVT Appoints Jennifer Murphy as Senior Vice President of Global Commercial Operations

Jennifer has more than 16 years’ commercial leadership experience in the diagnostics and life sciences industries.

Ripple Science and Curavit Clinical Research Sign Partnership Agreement to Accelerate Decentralized Clinical Trials (DCTs)

Ripple Enterprise software to be deployed as part of the digital transformation in clinical trials spearheaded by Curavit.

DFE Pharma, Harro Höfliger, and Sterling partner in “INTO” to provide formulation services for respiratory products

DFE Pharma, Harro Höfliger, and Sterling partner in “INTO” to provide formulation services for respiratory products Inhalation Together (INTO) helps pharmaceutical companies in the respiratory field to simplify formulation development New York, USA (24th March 2022) – Three leading companies in their respective fields - DFE Pharma (excipients solution provider), Harro Höfliger (equipment supplier), and Sterling (API manufacturer) - announced a unique partnership with the establishment of “Inhalation Together” (INTO) in the field of dry powder inhalation (DPI).

BOC Sciences Optimizes PROTAC Platform to Boost Related Research

BOC Sciences optimizes its PROTAC platform of protein degradation technology to boost PROTAC research and development.

Creative Bioarray Develops Cell Immortalization Kits and Immortalized Human Cells to Support Immortalized Cell Research